China's top drug regulator said it approved Merck & Co.'s Molnupiravir for emergency use on Thursday. "China Approves Merck's Molnupiravir for Emergency Use, Regulator Says," at 0809 GMT, incorrectly said the approval came on Wednesday.

(END) Dow Jones Newswires

December 30, 2022 03:52 ET (08:52 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Merck Charts.